2005
DOI: 10.1038/labinvest.3700304
|View full text |Cite
|
Sign up to set email alerts
|

Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration

Abstract: The regression of cirrhosis is associated with increased intrahepatic collagenolytic enzyme activity. We investigated whether collagenase supplementation via portal vein infusion can retard cirrhosis development and/or reverse cirrhosis. In all, 35 rabbits were initially assigned to study. However, because of high surgical mortality and infection, only 15 animals completed study. Four normal controls (group I) received olive oil subcutaneously (SC) for 12 weeks followed by normal saline portal perfusion for 12… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 35 publications
1
4
0
1
Order By: Relevance
“…In conclusion, data obtained during the present study: (1) demonstrate that the loss of SECs during CI‐WR has no effect on the overall function of cirrhotic rat livers; and (2) strongly suggest that collagenization is more important than capillarization in the reduced exchange between sinusoids and hepatocytes in these cirrhotic rat livers. It is therefore tempting to hypothesize than use of matrix metalloproteinase or collagenase, while administered through the portal vein, may well retard cirrhosis development or even induce regression of established cirrhosis, as it has been shown in preliminary experimental studies 32, 33. These provocative findings should be first confirmed in additional animal studies before a potential application to human cirrhosis treatment, but they are further supported by the present data showing a preponderant role for the hepatic collagenization.…”
Section: Discussionsupporting
confidence: 72%
“…In conclusion, data obtained during the present study: (1) demonstrate that the loss of SECs during CI‐WR has no effect on the overall function of cirrhotic rat livers; and (2) strongly suggest that collagenization is more important than capillarization in the reduced exchange between sinusoids and hepatocytes in these cirrhotic rat livers. It is therefore tempting to hypothesize than use of matrix metalloproteinase or collagenase, while administered through the portal vein, may well retard cirrhosis development or even induce regression of established cirrhosis, as it has been shown in preliminary experimental studies 32, 33. These provocative findings should be first confirmed in additional animal studies before a potential application to human cirrhosis treatment, but they are further supported by the present data showing a preponderant role for the hepatic collagenization.…”
Section: Discussionsupporting
confidence: 72%
“…The continuing progress in biotechnological and medical research is uncovering an ever-growing number of possible applications for clostridial collagenases, in particular ColG and H (Antonioli et al 2007; Chu 1987; Jin et al 2005; Jordan 2008; Ku et al 1993; Kuriyama et al 2001; Segev et al 2005; Wang et al 2004). There are various commercial preparations available, but these usually contain several collagenase isoforms and even other proteases (e.g., clostripain).…”
Section: Discussionmentioning
confidence: 99%
“…Hepatic fibrosis is successfully induced in rabbits by subcutaneous injection of CCl 4 [9]. To test the pharmacodynamic effects of mivacurium following the severity of liver dysfunction in an experimental model, we examined dose-response relationships and the duration of neuromuscular blockade and confirmed the relationship between recovery indices and plasma cholinesterase.…”
Section: Introductionmentioning
confidence: 99%